Pablo Miguel
Barreiro Garcia
Hospital Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Carlos III (225)
2020
-
Coronavirus and other airborne agents with pandemic potential
Current Opinion in Environmental Science and Health, Vol. 17, pp. 41-48
-
Long-acting antiretroviral therapy
Nature Materials, Vol. 19, Núm. 8, pp. 826-827
-
Very long-acting antivirals as chemovaccines for preventing viral infections
AIDS Reviews
-
Why such excess of mortality for COVID-19 in Spain?
Therapeutic Advances in Infectious Disease
2018
2017
-
Diagnosis of cutaneous anthrax in resource-poor settings in west Arsi Province, Ethiopia
Annals of Agricultural and Environmental Medicine, Vol. 24, Núm. 4, pp. 712-715
-
Is Ribavirin Teratogenic in Humans? No Evidence So Far
Drug Safety
-
Malaria and severe anemia over eight years at Gambo Rural Hospital, southern Ethiopia
Pathogens and Global Health, Vol. 111, Núm. 4, pp. 195-199
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
2016
-
First Case of Zika Virus Infection in a HIV+ Patient
AIDS reviews, Vol. 18, Núm. 2, pp. 112
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
-
Prevalence of positive HIV, HBV, HCV and treponemal tests in blood donors in a rural hospital in southern Ethiopia
Journal of Clinical Virology
2015
-
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients
Antiviral Therapy, Vol. 20, Núm. 3, pp. 329-334
-
Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C
Antiviral Therapy, Vol. 20, Núm. 1, pp. 65-72
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Association of low-density lipoprotein receptor genotypes with hepatitis C viral load
Genes and Immunity, Vol. 15, Núm. 1, pp. 16-24
-
Causas que justifican el cambio del tratamiento antirretroviral en personas con infección por el VIH en España (años 2010-2011). Estudio SWITCH AUDIT
Revista Espanola de Quimioterapia, Vol. 27, Núm. 2, pp. 93-97
-
Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy
Journal of Viral Hepatitis, Vol. 21, Núm. 7, pp. 475-479